On August 15, 2019, the Marijuana Enforcement Division (MED) officially confirmed the implementation date for mandatory mycotoxin screening.

The start date is set for September 15, 2019.

Please see the following excerpt from INDUSTRY-WIDE BULLETIN: 19-04 (RE: MANDATORY MYCOTOXIN TESTING FOR MEDICAL AND RETAIL MARIJUANA CONCENTRATE PRODUCED FROM MEDICAL OR RETAIL MARIJUANA THAT FAILED MICROBIAL CONTAMINANT TESTING STARTING SEPTEMBER 15, 2019).

Pursuant to 44-11-202 (3)(a)(I) & 44-12‐202(3)(a)(IV) Colorado Revised Statutes (C.R.S.), with a determination that sufficient capacity exists with the certified Testing Facilities, the Marijuana Enforcement Division will implement mandatory Medical Marijuana and Retail Marijuana mycotoxin contaminant testing beginning Sunday, September 15, 2019. As of this date, all Medical Marijuana-Infused Products Manufacturers and Retail Marijuana Products Manufacturing Facilities are required to comply with MED Rules M 1501(C)(4) and/or R 1501(C)(5).

Mandatory mycotoxin contaminant testing applies to all Production Batches of Medical Marijuana Concentrate and Retail Marijuana Concentrate that were produced on or after September 15, 2019 and were produced from Medical or Retail Marijuana that failed microbial contaminant testing. Medical and Retail Marijuana Concentrate that is part of a Production Batch created prior to September 15, 2019 are not subject to mycotoxin contaminant testing requirements…

Mandatory Medical and Retail Marijuana mycotoxin testing is a matter of public health and safety and full compliance is expected to start Sunday, September 15, 2019.